Narinderpal Kaur
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Narinderpal Kaur has a total of 17 co-authors. Here are the top co-authors by number of shared publications:
- Ajar Nath Yadav
Department of Genetics, Plant Breeding and Biotechnology, Dr. Khem Singh Gill Akal College of Agriculture, Eternal University, Baru Sahib, Sirmour, Himachal Pradesh, India
1 shared publication - Balakumar Chandrasekaran
Department of Pharmaceutical Sciences, Faculty of Pharmacy, Zarqa University, Amman, Jordan
1 shared publication - Balraj Saini
Chitkara College of Pharmacy, Chitkara University
1 shared publication - Gurpreet Kaur
Department of Pharmaceutical Sciences and Drug Research, Punjabi University, Patiala 147002, Punjab, India
1 shared publication - Jangjeet Karan Singh
Chitkara College of Pharmacy, Chitkara University, Rajpura 140401, Punjab, India
1 shared publication - Neelam Thakur
Department of Zoology, Akal College of Basic Sciences, Eternal University, Baru Sahib, India
1 shared publication
Latest Publications
- Open Access
- 17 May 2025
- Published by Horizon E-Publishing Group in Plant Science Today
Biological control of greenhouse whiteflies (Trialeurodes vaporariorum) using indigenous Pseudomonas spp.: An eco- friendly approach
Soil deterioration and environmental degradation caused by harsh chemical pesticides have led to the search for suitable alternatives that can not only control pests but also promote plant growth. Pseudomonas spp. has been exploited immensely for its biocontrol and plant growth promotion attributes. This study isolated 5 indigenous bacterial strains from eight rhizospheric soil samples from Shimla and Sirmour districts of Himachal Pradesh and further screened them for traits such as siderophores production and hydrolytic enzyme (amylase and protease) activity. Screening data of isolates showed production of siderophores (19.56%), amylase (50%) and protease (71.73%). The strain EU- SIRCK1243 was positive for all three traits and was tested for indole-3-acetic acid (IAA) production yielding 2.03±0.30 ?g/mL (with tryptophan) and 4.23±0.17 ?g/mL (without tryptophan). It was molecularly identified as Pseudomonas aeruginosa, on the basis of 16S rRNA gene sequencing and evaluated for bioefficacy against Trialeurodes vaporariorum (greenhouse whitefly) on tomato plants over two years (2022-2023). The average adult population declined with overall percent reductions of 54.11% in 2022 and 62.04% in consecutive year 2023. In case of nymph populations the overall, reductions was 59.13% in 2022 and 62.20% in 2023. The plant growth and physiological parameters after treatment with EU- SIRCK1243 showed significant increase in shoot and root lengths, fresh, dry biomass, yield and chlorophyll content as compared to control. It is suggested that the strain EU-SIRCK1243 is a promising biocontrol agent for greenhouse whitefly and an effective plant growth promoting bacterium. In future deliberation, the better development of Pseudomonas aeruginosa bioproducts could be emphasized.
- 17 May 2025
- Published by Horizon E-Publishing Group in Plant Science Today
Open AccessBiological control of greenhouse whiteflies (Trialeurodes vaporariorum) using indigenous Pseudomonas spp.: An eco- friendly approach
Soil deterioration and environmental degradation caused by harsh chemical pesticides have led to the search for suitable alternatives that can not only control pests but also promote plant growth. Pseudomonas spp. has been exploited immensely for its biocontrol and plant growth promotion attributes. This study isolated 5 indigenous bacterial strains from eight rhizospheric soil samples from Shimla and Sirmour districts of Himachal Pradesh and further screened them for traits such as siderophores production and hydrolytic enzyme (amylase and protease) activity. Screening data of isolates showed production of siderophores (19.56%), amylase (50%) and protease (71.73%). The strain EU- SIRCK1243 was positive for all three traits and was tested for indole-3-acetic acid (IAA) production yielding 2.03±0.30 ?g/mL (with tryptophan) and 4.23±0.17 ?g/mL (without tryptophan). It was molecularly identified as Pseudomonas aeruginosa, on the basis of 16S rRNA gene sequencing and evaluated for bioefficacy against Trialeurodes vaporariorum (greenhouse whitefly) on tomato plants over two years (2022-2023). The average adult population declined with overall percent reductions of 54.11% in 2022 and 62.04% in consecutive year 2023. In case of nymph populations the overall, reductions was 59.13% in 2022 and 62.20% in 2023. The plant growth and physiological parameters after treatment with EU- SIRCK1243 showed significant increase in shoot and root lengths, fresh, dry biomass, yield and chlorophyll content as compared to control. It is suggested that the strain EU-SIRCK1243 is a promising biocontrol agent for greenhouse whitefly and an effective plant growth promoting bacterium. In future deliberation, the better development of Pseudomonas aeruginosa bioproducts could be emphasized.
- 29 January 2025
- Published by Springer Nature in Phytochemistry Reviews
- Vol. 24 (6) , 5239-5254
Safety concern of drugs of herbal origin
- 29 January 2025
- Published by Springer Nature in Phytochemistry Reviews
- Vol. 24 (6) , 5239-5254
Safety concern of drugs of herbal origin
- Open Access
A QbD-Navigated Approach to the Development and Evaluation of Etodolac–Phospholipid Complex Containing Polymeric Films for Improved Anti-Inflammatory Effect
The current study focuses on development of phospholipid complex-loaded films of etodolac for enhanced transdermal permeation and anti-inflammatory effect. An etodolac–phospholipid complex was developed using the solvent evaporation method and was characterized by DSC, XRD, FTIR, and 1H-NMR studies. The formation of the complex led to conversion of a crystalline drug to an amorphous form. A stoichiometric ratio of 1:1 (drug–phospholipid) was selected as the optimized ratio. Further, the developed complex was incorporated into films and systematic optimization using a central composite design was carried out using a response surface methodological approach. The desirable design space based on minimum contact angle and maximum tensile strength was selected, while the water vapour transmission rate and swelling index were set within limits. The results for swelling index, contact angle, tensile strength, and water vapour transmission rate were 60.14 ± 1.01%, 31.6 ± 0.03, 2.44 ± 0.39 kg/cm2, and 15.38 g/hm2, respectively. These values exhibited a good correlation with the model-predicted values. The optimized formulation exhibited improved diffusion and permeation across skin. In vivo studies revealed enhanced anti-inflammatory potential of the developed films in comparison to the un-complexed drug. Hence, the study demonstrated that etodolac–phospholipid complex-loaded films improve the transdermal permeation and provided enhanced anti-inflammatory effect.
Open AccessA QbD-Navigated Approach to the Development and Evaluation of Etodolac–Phospholipid Complex Containing Polymeric Films for Improved Anti-Inflammatory Effect
The current study focuses on development of phospholipid complex-loaded films of etodolac for enhanced transdermal permeation and anti-inflammatory effect. An etodolac–phospholipid complex was developed using the solvent evaporation method and was characterized by DSC, XRD, FTIR, and 1H-NMR studies. The formation of the complex led to conversion of a crystalline drug to an amorphous form. A stoichiometric ratio of 1:1 (drug–phospholipid) was selected as the optimized ratio. Further, the developed complex was incorporated into films and systematic optimization using a central composite design was carried out using a response surface methodological approach. The desirable design space based on minimum contact angle and maximum tensile strength was selected, while the water vapour transmission rate and swelling index were set within limits. The results for swelling index, contact angle, tensile strength, and water vapour transmission rate were 60.14 ± 1.01%, 31.6 ± 0.03, 2.44 ± 0.39 kg/cm2, and 15.38 g/hm2, respectively. These values exhibited a good correlation with the model-predicted values. The optimized formulation exhibited improved diffusion and permeation across skin. In vivo studies revealed enhanced anti-inflammatory potential of the developed films in comparison to the un-complexed drug. Hence, the study demonstrated that etodolac–phospholipid complex-loaded films improve the transdermal permeation and provided enhanced anti-inflammatory effect.